Alan Mast Knows Firsthand How Far Blood Research Has Come
Versiti Blood Research Institute posted on LinkedIn:
”Alan Mast, MD, PhD, knows firsthand how far blood research has come. When his daughter developed a blood clot in her brain, he reflected on the power of progress: “50 years ago, she would have only had a 70% chance of survival. 30 years ago, she would have been in the hospital for two weeks, receiving intravenous solutions. Now she’s able to be treated as an outpatient with a pill.”
Today, Dr. Mast’s lab investigates Tissue Factor Pathway Inhibitor (TFPI), a protein that helps prevent clot formation. By studying how TFPI interacts with blood vessels and platelets, his team is advancing understanding of bleeding and clotting disorders—and helping bring precision medicine into vascular diagnostics.
Read the case study to learn more.”
Keep up with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy